Section 1
Overview of
Budd-Chiari Syndrome
Understanding the causes, mechanisms, and classification of hepatic venous outflow obstruction
Embedded Files
Welcome to Section 1: Etiology and Pathogenesis
Welcome to Section 1 of PathBud. In this section, you will explore the underlying causes and biological mechanisms of Budd-Chiari syndrome, a condition characterized by impaired blood flow out of the liver.
This section introduces how factors such as thrombosis*, hypercoagulable states*, and structural abnormalities lead to hepatic vein obstruction. You will also examine how these disruptions increase pressure within the liver, resulting in tissue injury, reduced perfusion, and progressive liver dysfunction.
To get the most out of this section, engage with the provided content and apply your understanding as you move through each section.
Definitions for terms with a star* beside them can be found in the index.
Learning Goals: Section 1
Explain the primary and secondary causes of Budd–Chiari syndrome
Describe how hepatic venous obstruction disrupts normal blood outflow
Understand how increased sinusoidal pressure leads to liver congestion
Explain how reduced perfusion and hypoxia cause hepatocellular injury
Describe the progression to portal hypertension, fibrosis, and chronic liver disease
Anatomy of The Liver
Introduction to the Etiology of Budd-Chiari Syndrome
Etiology of Budd-Chiari Syndrome
Budd-Chiari syndrome is a multifactorial disorder characterized by obstruction of hepatic venous outflow, most commonly at the level of the hepatic veins or inferior vena cava. It is a rare condition, with an estimated incidence of approximately 1 per 100,000 individuals worldwide 1.
Etiologically, BCS is divided into primary (intrinsic) and secondary (extrinsic) forms.
1. Primary Budd-Chiari Syndrome
Primary BCS accounts for the majority of cases and results from thrombosis within the hepatic veins, typically due to underlying hypercoagulable states.
Myeloproliferative Neoplasms
These are disorders of the bone marrow that lead to overproduction of blood cells, increasing blood viscosity and promoting clot formation. They are the most common cause, present in ~50% of BCS cases 2.
Inherited Thrombophilias (Genetic)
These are genetic conditions that increase the tendency for blood to clot, often due to abnormalities in coagulation proteins.
Factor V Leiden
Mutation that makes factor V resistant to inactivation by protein C, leading to prolonged clotting activity 1.
Prothrombin Gene Mutation G20210A
Increases levels of prothrombin, enhancing thrombin generation and clot formation 1.
Protein C/S Deficiency
Reduces natural anticoagulant activity, impairing the body's ability to limit clot formation 1.
Paroxysmal Nocturnal Hemoglobinuria
Rare hematologic* condition characterized by complement-mediated destruction of red blood cells, which is associated with a high risk of venous thrombosis in atypical sites, including hepatic veins 1.
Antiphospholipid Syndrome
Autoimmune disorder in which antibodies target phospholipid-binding proteins, resulting in increased risk of arterial and venous thrombosis 1.
Hormonal Factors
ie. pregnancy and oral contraceptives
These states increase levels of clotting factors and reduce anticoagulant activity, creating a prothrombotic environment 1,2.
They are implicated in up to 20% of cases 1,2.
2. Secondary Budd-Chiari Syndrome
Secondary BCS is less common and results from external compression or invasion of the hepatic veins/inferior vena cava 3.
Malignancies
Tumors may directly invade or compress venous structures 1.
Benign Masses / Cysts
Space-occupying lesions can cause mechanical compression of hepatic veins 1.
Congenital Abnormalities
Structural defects present from birth can narrow or obstruct venous outflow, particularly in certain geographic regions 1.
Introduction to the Pathogenesis of Budd-Chiari Syndrome
Pathogenesis of Budd-Chiari Syndrome
Budd-Chiari syndrome develops as a consequence of hepatic venous outflow obstruction, which disrupts normal blood drainage from the liver. This leads to a cascade of hemodynamic changes, cellular injury, and progressive liver dysfunction.
Here are the steps of pathogenesis.
1. Hepatic Venous Outflow Obstruction 1
Obstruction of the hepatic veins or inferior vena cava, most commonly due to thrombosis.
Blood is unable to exit the liver efficiently
Leads to a backlog of blood within the hepatic circulation
2. Increased Sinusoidal Pressure and Congestion 1
The impaired outflow from the obstruction causes blood to back up in the liver sinusoids*.
More blood in sinusoids = increased sinusoidal pressure
Hepatomegaly: abnormal enlargement of liver beyond it's normal size
This congestion primarily affects the centrilobular (zone 3) regions of the liver, which are most vulnerable to oxygen supply.
3. Reduced Perfusion and Hypoxia 1
As pressure builds within the liver, effective blood flow through hepatic tissue decreases.
Ischemia: reduced oxygen delivery
Hepatocellular injury, especially in zone 3 hepatocytes* which are already the most oxygen-poor regions
This creates a mismatch between oxygen supply and metabolic demand, worsening cellular damage.
4. Hepatocellular Necrosis and Inflammation 1
Prolonged hypoxia leads to:
Centrilobular necrosis: death of hepatocytes
Activation of inflammatory pathways
At this stage, patients may begin to develop acute liver injury or symptoms such as abdominal pain and elevated liver enzymes.
5. Development of Portal Hypertension 6
As hepatic blood flow becomes increasingly obstructed, pressure is transmitted backward into the portal system 5, leading to:
Portal hypertension
Formation of collateral circulation (alternate route for blood)
Development of ascites: accumulation of fluid in abdominal cavity
This represents a key transition from localized hepatic injury to systemic complications.
6. Fibrosis and Chronic Liver Disease 6
In chronic or untreated cases, ongoing injury and inflammation stimulate:
Fibrosis: excess deposition of connective tissue
Progressive architectural distortion of the liver
Eventual cirrhosis and liver failure
The extent and speed of progression depend on whether the obstruction is acute, subacute, or chronic 2.
Page updated
Google Sites
Report abuse